Skip to content
← Full study record

NCT01789255 · MORE INFO

Limitations, agreements, and source contact

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · Source last updated 2018-07-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
reddypr@umich.edu
organization
University of Michigan Comprehensive Cancer Center
phone
734-647-5954
title
Pavan Reddy, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
reddypr@umich.edu
organization
University of Michigan Comprehensive Cancer Center
phone
734-647-5954
title
Pavan Reddy, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice